Xencor (XNCR) FCF Margin Growth (1y) (2014 - 2026)
Powered by 
Analysis
Xencor (XNCR) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 811.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 19,111.00 |
| 10 | Xencor | 2.02 Bn | 1.64 Bn | - | -2,543.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,543.00 |
| Mar 31, 2026 | -145,706.00 |
| Dec 31, 2025 | -8,962.00 |
| Sep 30, 2025 | 1,768.00 |
| Jun 30, 2025 | 21,010.00 |
| Mar 31, 2025 | 30,230.00 |
| Dec 31, 2024 | -13,128.00 |
| Sep 30, 2024 | -11,443.00 |
| Jun 30, 2024 | -20,200.00 |
| Mar 31, 2024 | -13,838.00 |
| Dec 31, 2023 | 19,297.00 |
| Sep 30, 2023 | 501.00 |
| Jun 30, 2023 | -19,806.00 |
| Mar 31, 2023 | -22,224.00 |
| Dec 31, 2022 | -19,526.00 |
| Sep 30, 2022 | 15,615.00 |
| Jun 30, 2022 | 12,338.00 |
| Mar 31, 2022 | 9,823.00 |
| Dec 31, 2021 | 272.00 |
| Sep 30, 2021 | -18,784.00 |